Abstract
A sustaining or causal role for renin in essential hypertension has at least begun to gain credence along with the concept that essential hypertension is not a single clinical entity. Indeed, only recently has renin secretion been implicated in renovascular hypertension; renin measurements were not included even in the broad 1972 evaluation of renovascular hypertension formulated by the National Cooperative Study Group (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vaughan ED Jr, Laragh JH (1975) New concepts of the renin system and of vasoconstriction-volume mechanisms: Diagnosis and treatment of renovascular and renal hypertension. Urol Clin North Am 2: 237–257
Laragh JH, Ulick S, Januszewicz V, Demin QB, Kelly WG, Lieberman S (1960) Aldosterone secretion and primary and malignant hypertension. J Clin Invest 39: 1091–1106
Laragh JH, Angers M, Kelly WG, Lieberman S (1960) Hypotensive agents and pressor substances: The effect of epinephrine, norepinephrine, angiotensin II and others on the secretory rate of aldosterone in man. JAMA 174: 234–240
Laragh JH (1960) The role of aldosterone in man: Evidence for regulation of electrolyte balance and arterial pressure by renal-adrenal system which may be involved in malignant hypertension. JAMA 174: 293–295
Laragh JH, Sealey JE (1973) The renin-angiotensin- aldosterone hormonal system and regulation of sodium, potassium, and blood pressure homeostasis. In: Orloff J, Berliner RW (eds) American Physiological Society (Handbook of physiology—renal physiology). Waverly Press, Baltimore, pp 831–908
Sealey JE, Laragh JH (1974) A proposed cybernetic system for sodium and potassium homeostasis: Coordination of aldosterone and intrarenal physical factors. Kidney Int 6: 281–290
Bühler FR, Laragh JH, Baer L, Vaughan ED Jr, Brunner HR (1972) Propranolol inhibition of renin secretion: A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 287: 1209–1214
Laragh JH, Baer L, Brunner HR, Bühler FR, Sealey JE, Vaughan ED Jr (1972) Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 52: 633–652
Sealey JE, Laragh JH (1977) How to do a plasma renin assay. Cardiovasc Med 2: 1079–1092
Sealey JE, Laragh JH (1975) “Prorenin” in human plasma? Methodological and physiological implications. Circ Res 36, 37(Suppl I): I-10–I-16
Ryan MP, Weinberger MH (1980) Effect of sulphy-dryl reagents on the enzymatic activity of human renin: Implications for renin assay. Clin Chim Acta106: 135–143
Laragh JH, Sealey JE, Ledingham JGG, Newton MA (1967) Oral contraceptives: Renin, aldosterone and high blood pressure. JAMA 201: 918–922
Ames RP, Borkowski AJ, Sicinski AM, Laragh JH (1965) Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, aldosterone and Cortisol secretion in normal man and in cirrhosis with ascites. J Clin Invest 44: 1171–1186
Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, Bard RH, Buhler FR (1972) Essential hypertension: Renin and aldosterone, heart attack and stroke. N Engl J Med 286: 441–449
Brunner HR, Sealey JE, Laragh JH (1973) Renin as a risk factor in essential hypertension: More evidence. Am J Med 55: 295–302
Orjavik OS, Aas M, Fauchold P, et al (1975) Renin secreting tumors with severe hypertension. Acta Med Scand 197: 329–336
Perera GN, Haelig AW (1952) Clinical characteristics of hypertension associated with unilateral renal disease. Circulation 6: 349
Davis BA, Crook JE, Vestal RE, Oates JA (1979) Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med 301: 1273–1276
Gavras H, Brunner HR, Laragh JH (1974) Renin and aldosterone and the pathogenesis of hypertensive vascular damage. Prog Cardiovasc Dis 17: 39–49
Laragh JH (1978) Renin as a predictor of hypertensive complications: Discussion. Ann NY Acad Sci 304: 165–177
Keim HJ, Drayer JIM, Case DB, Lopez-Ovejero J A, Wallace JM, Laragh JH (1976) A role for renin in rebound hypertension and encephalopathy after infusion of sar1-ala8-angiotensin II. N Engl J Med 295: 1175–1177
Laragh JH (1978) The renin system in high blood pressure, from disbelief to reality: Converting enzyme blockade for analysis and treatment. Prog Cardiovasc Dis 21: 159–166
Amery A, Lijnen P, Fagard R, Reybrouck T (1976) Plasma renin activity vs. concentration. N Engl J Med 295: 1198C
Brunner HR, Gavras H, Laragh JH (1973) Angiotensin II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood pressure. Lancet 2: 1045–1048
Case DB, Wallace JM, Keim HJ, Sealey JE, Laragh JH (1976) Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II for evaluating the renin and sodium factors in hypertensive patients. Am J Med 60: 825–836
Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JIM, White RP, Sealey JE, Laragh JH (1976) Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin. Am J Med 61: 790–796
Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, Vukovitch RA (1974) An angiotensin converting enzyme inhibitor to identify and treat vasoconstriction and volume factors in hypertensive patients. New Engl J Med 291: 817–821
Case DB, Wallace JM, Keim HJ, Weber MA, Sealey JE, Laragh JH (1977) Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med 296: 641–646
Case DB, Atlas SA, Laragh JH, Sealey JE, Sullivan PA, McKinstry DN (1978) Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis 21: 195–206
Brunner HR, Gavras H, Laragh JH, KeenanR (1974) Hypertension in man: Exposure of the renin and sodium components using angiotensin II blockade. Circ Res 34, 35(Suppl. I): I-35–I-45
Brunner HR, Kirshman JD, Sealey JE, Laragh JH(1971) Hypertension of renal origin: Evidence for two different mechanisms. Science 174: 1344–1346
Gavras H, Brunner HR, Vaughan ED Jr, Laragh JH (1973) Angiotensin-sodium interaction in blood pressure maintenance of renal hypertensive and nor-motensive rats. Science 180: 1369–1372
Laragh JH (1973) Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles. Am J Med 55: 261–274
Tarazi RC, Dustan HP (1972) Beta adrenergic blockade in hypertension. Am J Cardiol 29: 633
Laragh JH, Letcher RL, Pickering TG (1979) Renin profiling for modern diagnosis and treatment of hypertension. JAMA 241: 151–156
Esler M, Randall O, Bennett J, et al (1976) Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet 2: 115–118
Weidmann P, Hirsch D, Beretta-Piccol C, et al (1977) Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. Am J Med 62: 209–218
Laragh JH (1976) Modern system for treating high blood pressure based on renin profiling and vasoconstriction volume analysis: A primary role for beta blocking drugs such as propranolol. Am J Med 61: 797–810
Laragh JH, Sealey JE (1977) Renin-sodium profiling: Why, how and when in clinical practice. Cardiovasc Med 2: 1053–1075
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag New York Inc.
About this paper
Cite this paper
Laragh, J.H. (1981). Position Paper: The Renin-Angiotensin-Aldosterone System for Blood Pressure Regulation and for Subdividing Patients to Reveal and Analyze Different Forms of Hypertension. In: Laragh, J.H., Bühler, F.R., Seldin, D.W. (eds) Frontiers in Hypertension Research. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5899-5_34
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5899-5_34
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-5901-5
Online ISBN: 978-1-4612-5899-5
eBook Packages: Springer Book Archive